LP
EW icon

LMR Partners’s Edwards Lifesciences EW Stock Holding History

LMR Partners’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-107,200
Closed -$7.07M – 1326
2024
Q3 		$7.07M Buy
+107,200
New +$7.79M 0.06% 289

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

LMR Partners's EW Position: Q1 2026 in Review

LMR Partners opened a new position in Edwards Lifesciences (EW) in Q1 2026: 31,672 shares worth $2.54M. The stake represents 0.01% of the portfolio and ranks #807 among its holdings. This is a return to the name: LMR Partners previously reported a position in EW as recently as Q3 2025.

LMR Partners first reported a position in EW in Q1 2014 and has held it in 31 quarters since. The position peaked at $9.89M in Q4 2024. 1,284 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • LMR Partners held 31,672 shares of Edwards Lifesciences worth $2.54M as of Q1 2026.
  • Edwards Lifesciences was a new LMR Partners position in Q1 2026.
  • Edwards Lifesciences made up 0.01% of LMR Partners's portfolio in Q1 2026, its #807 holding.
  • LMR Partners first reported a position in Edwards Lifesciences in Q1 2014 and has held it in 31 quarters since.
  • LMR Partners's Edwards Lifesciences position peaked at $9.89M in Q4 2024.
  • 1,284 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on LMR Partners's 13F filing for Q1 2026, filed 15 May 2026.